Maurice Zauderer

Person

Pitsford, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Use of semaphorin-4D antibodies in combination with an immune modul...
- Patent number 12,070,500
- Issue date Aug 27, 2024
- Vaccinex, Inc.
- Elizabeth E. Evans
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Human anti-semaphorin 4D antibody
- Patent number 12,006,365
- Issue date Jun 11, 2024
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of semaphorin-4D binding molecules for the treatment of Rett sy...
- Patent number 11,597,765
- Issue date Mar 7, 2023
- Vaccinex, Inc.
- Yilin Mao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer with a semaphorin-4D antibody in combination wi...
- Patent number 11,572,408
- Issue date Feb 7, 2023
- Vaccinex, Inc.
- Elizabeth Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of semaphorin-4D binding molecules for modulation of blood brai...
- Patent number 11,534,488
- Issue date Dec 27, 2022
- Vaccinex, Inc.
- Ernest S. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human anti-semaphorin 4D antibody
- Patent number 11,427,634
- Issue date Aug 30, 2022
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of semaphorin-4D inhibitory molecules with an immune modulating...
- Patent number 11,078,295
- Issue date Aug 3, 2021
- Vaccinex, Inc.
- Elizabeth Evans
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of semaphorin-4D binding molecules for treating neurodegenerati...
- Patent number 10,800,853
- Issue date Oct 13, 2020
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for selecting polynucleotides encoding antigen-specific immu...
- Patent number 10,662,422
- Issue date May 26, 2020
- Vaccinex, Inc.
- Ernest S. Smith
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Use of anti-semaphorin-4D antibodies in combination with an immune...
- Patent number 10,526,414
- Issue date Jan 7, 2020
- Vaccinex, Inc.
- Elizabeth E. Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of semaphorin-4D binding molecules to promote neurogenesis foll...
- Patent number 10,494,440
- Issue date Dec 3, 2019
- Vaccinex, Inc.
- Ernest S. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of semaphorin-4D binding molecules for treating neurodegenerati...
- Patent number 10,385,136
- Issue date Aug 20, 2019
- Vaccinex, Inc.
- Ernest S. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified glycolipids and methods of making and using the same
- Patent number 10,111,950
- Issue date Oct 30, 2018
- Vaccinex, Inc.
- Steven A. Porcelli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for the treatment of B cell-mediated inflammatory diseases
- Patent number 9,890,213
- Issue date Feb 13, 2018
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of antibodies or antigen-binding fragments thereof that specifi...
- Patent number 9,828,435
- Issue date Nov 28, 2017
- Vaccinex, Inc.
- Elizabeth E. Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted CD1d molecules
- Patent number 9,809,654
- Issue date Nov 7, 2017
- Vaccinex, Inc.
- Bruno Robert
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for increasing immunoglobulin A levels
- Patent number 9,790,271
- Issue date Oct 17, 2017
- Vaccinex, Inc.
- Maurice Zauderer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion proteins to facilitate selection of cells infected with spec...
- Patent number 9,708,601
- Issue date Jul 18, 2017
- Vaccinex, Inc.
- Ernest S. Smith
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Method for selecting polynucleotides encoding antigen-specific immu...
- Patent number 9,701,958
- Issue date Jul 11, 2017
- Vaccinex, Inc.
- Ernest S. Smith
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Use of semaphorin-4D binding molecules for treating neurodegenerati...
- Patent number 9,598,495
- Issue date Mar 21, 2017
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of semaphorin-4D binding molecules for treatment of atheroscler...
- Patent number 9,512,224
- Issue date Dec 6, 2016
- Vaccinex, Inc.
- Maurice Zauderer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified glycolipids and methods of making and using the same
- Patent number 9,371,352
- Issue date Jun 21, 2016
- Vaccinex, Inc.
- Steven A. Porcelli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of semaphorin-4D binding molecules for treating neurodegenerati...
- Patent number 9,249,227
- Issue date Feb 2, 2016
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of SEMA-4D inhibitors and immunomodulators to inhibit t...
- Patent number 9,243,068
- Issue date Jan 26, 2016
- Vaccinex, Inc.
- Elizabeth E. Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-SEMA4D antibodies and epitopes
- Patent number 9,090,709
- Issue date Jul 28, 2015
- Vaccinex, Inc.
- Terrence Lee Fisher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
In vitro methods of producing and identifying immunoglobulin molecu...
- Patent number 8,741,810
- Issue date Jun 3, 2014
- University of Rochester
- Maurice Zauderer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-C35 antibody combination therapies and methods
- Patent number 8,637,026
- Issue date Jan 28, 2014
- Vaccinex, Inc.
- Maurice Zauderer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that bind to the C35 polypeptide
- Patent number 7,968,688
- Issue date Jun 28, 2011
- University of Rochester
- Maurice Zauderer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human anti-CD100 antibodies
- Patent number 7,919,594
- Issue date Apr 5, 2011
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene differentially expressed in breast and bladder cancer and enco...
- Patent number 7,910,551
- Issue date Mar 22, 2011
- University of Rochester
- Maurice Zauderer
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Use of PD-L1 Low Expression Status to Select Subjects for Cancer Im...
- Publication number 20250052757
- Publication date Feb 13, 2025
- Vaccinex, Inc.
- Elizabeth EVANS
- G01 - MEASURING TESTING
Information Patent Application
USE OF SEMAPHORIN-4D ANTIBODIES IN COMBINATION WITH AN IMMUNE MODUL...
- Publication number 20250032609
- Publication date Jan 30, 2025
- Vaccinex, Inc.
- Elizabeth E. Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTI-SEMAPHORIN 4D ANTIBODY
- Publication number 20240309091
- Publication date Sep 19, 2024
- Vaccinex, Inc.
- Ernest S. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH SEMAPHORIN-4D BLOCKADE AND HTT-LOWERING AG...
- Publication number 20230331863
- Publication date Oct 19, 2023
- Vaccinex, Inc.
- Elizabeth Evans
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PREDICTIVE OUTCOME PROFILING FOR USE OF AN ANTI-SEMAPHORIN-4D BINDI...
- Publication number 20230101618
- Publication date Mar 30, 2023
- Vaccinex, Inc.
- Maurice Zauderer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTI-SEMAPHORIN 4D ANTIBODY
- Publication number 20220356249
- Publication date Nov 10, 2022
- Vaccinex, Inc.
- Ernest S. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR THE TREATMENT OF RETT SY...
- Publication number 20210403559
- Publication date Dec 30, 2021
- Vaccinex, Inc.
- Yilin Mao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF SEMAPHORIN-4D INHIBITORY MOLECULES WITH AN IMMUNE MODULATING...
- Publication number 20210324103
- Publication date Oct 21, 2021
- Vaccinex, Inc.
- Elizabeth E. Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH A SEMAPHORIN-4D ANTIBODY IN COMBINATION WI...
- Publication number 20210179708
- Publication date Jun 17, 2021
- Vaccinex, Inc.
- Elizabeth EVANS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN ANTI-SEMAPHORIN 4D ANTIBODY
- Publication number 20210032329
- Publication date Feb 4, 2021
- Vaccinex, Inc.
- Ernest S. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SEMAPHORIN-4D ANTAGONISTS FOR USE IN CANCER THERAPY
- Publication number 20200317788
- Publication date Oct 8, 2020
- Vaccinex, Inc.
- Terrence Lee Fisher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EARLY DETECTION OF GLIAL CELL ACTIVATION IN NEURODEGENERATIVE OR NE...
- Publication number 20190383836
- Publication date Dec 19, 2019
- Vaccinex, Inc.
- Maurice ZAUDERER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR MODULATION OF BLOOD BRAI...
- Publication number 20190358321
- Publication date Nov 28, 2019
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATI...
- Publication number 20190322757
- Publication date Oct 24, 2019
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ANTI-SEMAPHORIN-4D ANTIBODIES MOLECULES WITH AN IMMUNE MODUL...
- Publication number 20190248914
- Publication date Aug 15, 2019
- Vaccinex, Inc.
- Elizabeth Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF SEMAPHORIN-4D INHIBITORY MOLECULES IN COMBINATION WITH AN IM...
- Publication number 20170335008
- Publication date Nov 23, 2017
- Vaccinex, Inc.
- Elizabeth E. Evans
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODULATION OF NKT CELL ACTIVITY WITH ANTIGEN-LOADED CD1d MOLECULES
- Publication number 20170312356
- Publication date Nov 2, 2017
- Vaccinex, Inc.
- Alena DONDA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR SELECTING POLYNUCLEOTIDES ENCODING ANTIGEN-SPECIFIC IMMU...
- Publication number 20170306318
- Publication date Oct 26, 2017
- Vaccinex, Inc.
- Ernest S. Smith
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Application
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATI...
- Publication number 20170198053
- Publication date Jul 13, 2017
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED GLYCOLIPIDS AND METHODS OF MAKING AND USING THE SAME
- Publication number 20160346384
- Publication date Dec 1, 2016
- Vaccinex, Inc.
- Steven A. Porcelli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for Selecting Polynucleotides Encoding Antigen-Specific Immu...
- Publication number 20160152971
- Publication date Jun 2, 2016
- Vaccinex, Inc.
- Ernest S. Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF SEMAPHORIN-4D INHIBITORY MOLECULES IN COMBINATION WITH AN IM...
- Publication number 20160115240
- Publication date Apr 28, 2016
- Vaccinex, Inc.
- Elizabeth E. Evans
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR INCREASING IMMUNOGLOBULIN A LEVELS
- Publication number 20150368332
- Publication date Dec 24, 2015
- Vaccinex, Inc.
- Maurice Zauderer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATI...
- Publication number 20150353641
- Publication date Dec 10, 2015
- Vaccinex, Inc.
- Ernest S. Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR THE TREATMENT OF B CELL-MEDIATED INFLAMMATORY DISEASES
- Publication number 20150125467
- Publication date May 7, 2015
- Vaccinex, Inc.
- Ernest S. SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Semaphorin-4D Binding Molecules for Treating Neurodegenerati...
- Publication number 20150110800
- Publication date Apr 23, 2015
- Vaccinex, Inc.
- Ernest S. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of Semaphorin-4D Binding Molecules for Treatment of Atheroscler...
- Publication number 20150104462
- Publication date Apr 16, 2015
- Vaccinex, Inc.
- Maurice Zauderer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination of SEMA-4D Inhibitors and Immunomodulators to Inhibit T...
- Publication number 20150044219
- Publication date Feb 12, 2015
- Vaccinex, Inc.
- Elizabeth E. Evans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED GLYCOLIPIDS AND METHODS OF MAKING AND USING THE SAME
- Publication number 20140227296
- Publication date Aug 14, 2014
- Steven A. Porcelli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-SEMA4D ANTIBODIES AND EPITOPES
- Publication number 20140099334
- Publication date Apr 10, 2014
- Vaccinex, Inc.
- TERRENCE LEE FISHER
- C07 - ORGANIC CHEMISTRY

Maurice Zauderer

Person

Patents Grantslast 30 patents

Use of semaphorin-4D antibodies in combination with an immune modul...

Human anti-semaphorin 4D antibody

Use of semaphorin-4D binding molecules for the treatment of Rett sy...

Treatment of cancer with a semaphorin-4D antibody in combination wi...

Use of semaphorin-4D binding molecules for modulation of blood brai...

Human anti-semaphorin 4D antibody

Use of semaphorin-4D inhibitory molecules with an immune modulating...

Use of semaphorin-4D binding molecules for treating neurodegenerati...

Method for selecting polynucleotides encoding antigen-specific immu...

Use of anti-semaphorin-4D antibodies in combination with an immune...

Use of semaphorin-4D binding molecules to promote neurogenesis foll...

Use of semaphorin-4D binding molecules for treating neurodegenerati...

Modified glycolipids and methods of making and using the same

Methods for the treatment of B cell-mediated inflammatory diseases

Use of antibodies or antigen-binding fragments thereof that specifi...

Targeted CD1d molecules

Methods for increasing immunoglobulin A levels

Fusion proteins to facilitate selection of cells infected with spec...

Method for selecting polynucleotides encoding antigen-specific immu...

Use of semaphorin-4D binding molecules for treating neurodegenerati...

Use of semaphorin-4D binding molecules for treatment of atheroscler...

Modified glycolipids and methods of making and using the same

Use of semaphorin-4D binding molecules for treating neurodegenerati...

Combination of SEMA-4D inhibitors and immunomodulators to inhibit t...

Anti-SEMA4D antibodies and epitopes

In vitro methods of producing and identifying immunoglobulin molecu...

Anti-C35 antibody combination therapies and methods

Antibodies that bind to the C35 polypeptide

Human anti-CD100 antibodies

Gene differentially expressed in breast and bladder cancer and enco...

Patents Applicationslast 30 patents

Use of PD-L1 Low Expression Status to Select Subjects for Cancer Im...

USE OF SEMAPHORIN-4D ANTIBODIES IN COMBINATION WITH AN IMMUNE MODUL...

HUMAN ANTI-SEMAPHORIN 4D ANTIBODY

COMBINATION THERAPY WITH SEMAPHORIN-4D BLOCKADE AND HTT-LOWERING AG...

PREDICTIVE OUTCOME PROFILING FOR USE OF AN ANTI-SEMAPHORIN-4D BINDI...

HUMAN ANTI-SEMAPHORIN 4D ANTIBODY

USE OF SEMAPHORIN-4D BINDING MOLECULES FOR THE TREATMENT OF RETT SY...

USE OF SEMAPHORIN-4D INHIBITORY MOLECULES WITH AN IMMUNE MODULATING...

TREATMENT OF CANCER WITH A SEMAPHORIN-4D ANTIBODY IN COMBINATION WI...

HUMAN ANTI-SEMAPHORIN 4D ANTIBODY

SEMAPHORIN-4D ANTAGONISTS FOR USE IN CANCER THERAPY

EARLY DETECTION OF GLIAL CELL ACTIVATION IN NEURODEGENERATIVE OR NE...

USE OF SEMAPHORIN-4D BINDING MOLECULES FOR MODULATION OF BLOOD BRAI...

USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATI...

USE OF ANTI-SEMAPHORIN-4D ANTIBODIES MOLECULES WITH AN IMMUNE MODUL...

USE OF SEMAPHORIN-4D INHIBITORY MOLECULES IN COMBINATION WITH AN IM...

MODULATION OF NKT CELL ACTIVITY WITH ANTIGEN-LOADED CD1d MOLECULES

METHOD FOR SELECTING POLYNUCLEOTIDES ENCODING ANTIGEN-SPECIFIC IMMU...

USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATI...

MODIFIED GLYCOLIPIDS AND METHODS OF MAKING AND USING THE SAME

Method for Selecting Polynucleotides Encoding Antigen-Specific Immu...

USE OF SEMAPHORIN-4D INHIBITORY MOLECULES IN COMBINATION WITH AN IM...

METHODS FOR INCREASING IMMUNOGLOBULIN A LEVELS

USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATI...

METHODS FOR THE TREATMENT OF B CELL-MEDIATED INFLAMMATORY DISEASES

Use of Semaphorin-4D Binding Molecules for Treating Neurodegenerati...

Use of Semaphorin-4D Binding Molecules for Treatment of Atheroscler...

Combination of SEMA-4D Inhibitors and Immunomodulators to Inhibit T...

MODIFIED GLYCOLIPIDS AND METHODS OF MAKING AND USING THE SAME

ANTI-SEMA4D ANTIBODIES AND EPITOPES